Abstract

A number of Raf-associated proteins have recently been identified, including members of the 14-3-3 family of phosphoserine-binding proteins. Although both positive and negative regulatory functions have been ascribed for 14-3-3 interactions with Raf-1, the mechanisms by which 14-3-3 binding modulates Raf activity have not been fully established. We report that mutational disruption of 14-3-3 binding to the B-Raf catalytic domain inhibits B-Raf biological activity. Expression of the isolated B-Raf catalytic domain (B-Rafcat) induces PC12 cell differentiation in the absence of nerve growth factor. By contrast, the B-Rafcat 14-3-3 binding mutant, B-Rafcat S728A, was severely compromised for the induction of PC12 cell differentiation. Interestingly, the B-Rafcat 14-3-3 binding mutant retained significant in vitro catalytic activity. In Xenopus oocytes, the analogous full-length B-Raf 14-3-3 binding mutant blocked progesterone-stimulated maturation and the activation of endogenous mitogen-activated protein kinase kinase and mitogen-activated protein kinase. Similarly, the full-length B-Raf 14-3-3 binding mutant inhibited nerve growth factor-stimulated PC12 cell differentiation. We conclude that 14-3-3 interaction with the catalytic domain is not required for kinase activity per se but is essential to couple B-Raf catalytic activity to downstream effector activation.

Highlights

  • Members of the Raf family of serine/threonine protein kinases have been shown to be key mediators of growth factor signaling in diverse biological systems

  • We utilized the yeast two-hybrid protein association assay to determine whether mutation of serine 728 to an alanine residue (S728A) disrupted 14-3-3 protein interaction with the catalytic domain of B-Raf

  • The cDNAs encoding the C-terminal catalytic domain (B-Rafcat) and a mutant encoding the serine to alanine change (B-Rafcat S728A) were subcloned in-frame with the GAL4 DNA binding domain of the yeast two-hybrid pAS1 vector

Read more

Summary

14-3-3 Couples B-Raf Activity to Effector Activation

Our findings suggest that 14-3-3 binding to the catalytic domain is not necessary for B-Raf kinase activity per se but rather facilitates B-Raf biological activity through the coupling of B-Raf to downstream effector complexes

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.